Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-23-069566

Chairman & CEO bought 350 shares at an average $17.45 ($6,108)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-06-07 Purchase : show line 1 in the form +230 $17.41 $4,004 3,229,409 D
2023-06-08 Purchase : show line 2 in the form +120 $17.53 $2,104 3,229,529 D
Open-market purchases · 350 sh · avg $17.45 · $6,108
Loading xslF345X04/tm2318125-1_4seq1.xml…